ArticleThe Prostate2019

Infiltrating CD4+ T cells attenuate chemotherapy sensitivity in prostate cancer via CCL5 signaling.

Peng Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.